欧米茄-3脂肪酸作为抗心律不良药:上游向调节剂,影响心脏结构和功能的急性和长期病理变化
David F Driscoll1,2, Francine K Welty3, Bruce R Bistrian4
1Stable Solutions LLC, Easton MA.
Critical care explorations
|September 27, 2023
概括
在冠状动脉旁路移植 (CABG) 后的术后心房动 (POAF) 是常见的. 欧米茄-3脂肪酸在减少炎症和减轻POAF风险方面表现有前途.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
背景情况:
- 手术后心房动 (POAF) 是冠状动脉旁路移植 (CABG) 手术后的常见并发症.
- POAF与短期和长期发病率和死亡率的增加有关.
- 手术前和手术后的炎症是POAF病理生理学的主要驱动因素.
研究的目的:
- 审查omega-3脂肪酸 (Ω-3脂肪酸) 在缓解POAF中的作用.
- 在CABG手术的背景下探索 Ω-3 脂肪酸的抗炎和抗节律性质.
主要方法:
- 使用PubMed.com进行了文献搜索.
- 选择了研究,重点关注接受隔离CABG手术的患者的并发症.
- 数据得到了定性评估和总结.
主要成果:
- 在CABG后,POAF影响大约30%的患者.
- 炎症被确定为POAF的主要原因.
- Ω-3脂肪酸具有抗炎性质,可以降低POAF的临床风险.
结论:
- 目前,对于CABG后的POAF没有确定的预防措施.
- 针对炎症反应可能会改善POAF的治疗结果.
- Ω-3脂肪酸可以通过调节eicosanoids和亲溶解媒介来减少急性炎症.
相关概念视频
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
1.0K
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
1.0K
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.4K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.4K
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
868
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
868
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
764
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
764
Mechanism of Cardiac Arrhythmias
943
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
943
Heart Failure Drugs: Inotropic Agents
611
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
611


